Background We present new findings on liver steatosis detected in a group of 20 morbidly obese patients who were reassessed shortly after bariatric surgery (BS) by assaying hepatic markers in their serum.
Introduction
In patients su¡ering from morbid obesity, the desired weight loss and return to general good health, with a state of metabolic and psychological balance, is rarely achieved by conventional medical treatment. Surgery is then indicated. 1 Bariatric surgery (BS), which involves vertical banded gastroplasty and gastric bypass surgery, works by restricting the amount of food ingested and hindering its absorption. 2, 3 Recent reports indicate that steatosis, the build-up of fat in the liver which is often associated with obesity, 4, 5 can progress to steatohepatitis, ¢brosis and cirrhosis of the liver and, rarely, liver-cell carcinoma. 6 The primary metabolic abnormalities that lead to fat accumulation in the liver are disturbances in the absorption, synthesis and degradation of lipid molecules. These are caused by an increased supply of fatty acids, increased synthesis of fatty acids in the liver, insu⁄cient b-oxidation of fatty acids and/or reduced synthesis or secretion of VLDL. 6, 7 Contradictory reports in the literature have prompted an interest in monitoring steatosis in obese subjects who underwent BS. On the one hand, it is reported that in most of these patients a substantial loss of weight after gastroplasty is accompanied by signs of recuperation from liver steatosis, while on the other, there are reports that BS may lead to an in£ammatory lesion (hepatitis) as a result of the rapid release of fatty acids or cytokines by the adipose tissue. 8--10 The detection, treatment and elimination of a risk factor for hepatocyte lesions, such as steatosis, could in most cases lead to a reversal of fatty degeneration and hence normalization of the results from clinical laboratory tests. 11 While there is a lack of consensus on this point, in the laboratory steatosis can be assessed via serum enzyme assays, since this condition can lead to overspill of cytoplasmic and/or mitochondrial liver enzymes into the circulation. 10, 12, 13 Thus, aspartate aminotransferase (AST), alanine aminotransferase (ALT) and lactate dehydrogenase (LD) are marker enzymes for hepatocyte lesions; alkaline phosphatase (ALP) and g-glutamyl transferase (g-GT) are cytoplasmic membrane enzymes indicative of cholestasis and cholinesterase (ChE) is a plasma-speci¢c enzyme marker for the synthetic capacity of the liver. 5 Other tests of liver function can provide information on the extent of steatosis, such as tests of excretion or retention of bilirubins and measurement of serum levels of cholesterol, albumin and total protein, which re£ect the capacity of the hepatocyte for synthesis, metabolism and transport. 14 In the study described here, the aim was to contribute new information on the condition of liver steatosis by analysing related variables measured before and followed for a short time after BS, because the available data on the period shortly after surgery are extremely scarce. 15 The present study was carried out with 20 of these patients (13 women and 7 men), aged 36.4712.3 years, the other 10 having been excluded because they lived in towns too far for the collection of data during the post-BS study period. The 20 patients were informed in writing of the questions demanded by the Ethical Committee of the Araraquara School of Pharmacy (UNESP University), who had approved the experimental protocol (No. 11/2003-CEP). Serum tests for hepatitis and cholestasis were negative in these patients; none drank more than 20 g of alcohol per day.
Methods

Patients
Procedure and measurements
All data samples, body weight, height measurements and blood samples for serum tests, were collected just before BS and one and three months after surgery. Weight and height were measured with a Lucas balance (capacity 300 kg --Lucastec, Sa ì o Paulo, Brazil) to which a height scale was coupled, standard methods being followed to ensure correct values were obtained reproducibly. The body mass index (BMI) was calculated by BMI ¼ W/h 2 (kg m 2 ), where W ¼ weight, h ¼ height. Blood samples (10 mL, evacuated tube) were taken from patients fasted for 12 h overnight. Serum determinations were performed in an Express-Plus automated biochemical analyser (Ciba Corning-Holliston, USA): AST, 16 ALT 17, 18 and LD, 19 were measured by ultraviolet-kinetic methods; d-GT 20 and ALP 21 were measured by kinetic methods; bilirubin was measured by a colorimetric method; 22, 23 cholesterol was measured by an enzymatic colorimetric method. 24 The ChE assay was carried out manually in the semiautomated Bio 2000-Celm apparatus (Sa ì o Paulo, Brazil) by the kinetic colorimetric method. 25 The biochemical analyses and enzyme assays were performed with Diasys diagnostic kits (Holzheim, Germany), except ChE, protein and albumin, for which Wiener kits (Goia OE nia, Brazil) were used (total protein, biuret method; 26 albumin, bromcresol green 26 ). All the serum enzyme assays were performed as recommended by the International Federation of Clinical Chemistry (IFCC).
Statistical analysis
Analysis of variance for repeated measurements was used to compare the mean values at the three sampling times. When data did not satisfy tests of normality or sphericity (respectively, the Shapiro--Wilk and Mauchly tests), they were subjected to logarithmic transformation or the Friedman non-parametric test. Multiple comparisons of means (Tukey test) or average rank (Nemenyi) followed.
Measured variables were compared with reference values by the Cochran test. Pearson's correlation coe⁄cient was used to estimate the correlation between the BMI and liver function markers.
A 5% level of signi¢cance was used throughout.
Results
Both the body weight and the BMI in preopertive period were signi¢cantly higher than the corresponding values of the ¢rst month after BS; similarly, those of the ¢rst month were higher than the corresponding values of the third month after BS (Table 1) . Overall, the mean losses were 8 kg/month in weight and 3 kg/m 2 per month in BMI, relative to pre-BS values.
Analysing the reductions seen in morbid obesity and weight after BS, these parameters behaved similar to the AST and ALT activities, which remained little changed one month after the operation, but fell signi¢cantly at the third month post-BS (Table 1) . Unlike the transaminases, LD activity did not show signi¢cant alteration between sampling periods. Among the serum levels of the hepatobiliary enzymes, g-GT and ALP (Table 1) , a signi¢cant fall was detected for g-GT, from the pre-surgery period to the third month post-BS and from one to three months post-BS.
It can be seen in Table1that the biochemical variable of measured serum bilirubin (direct and indirect), which relates to the condition of the liver (transport and conjugation functions), demonstrated no changes between the sampled periods ( Table 1 ). Serum markers for hepatic synthesis (ChE, albumin and total protein) and for synthesis and metabolism (serum cholesterol) did not show a signi¢cant change either ( Table 1) .
The proportion of individuals in whom serum markers of liver function were signi¢cantly di¡erent from reference intervals was also analysed. In this comparative test, results for each patient were compared with the reference interval for the corresponding gender to allow for known di¡erences between genders in the normal ranges. It was found that just one variable was altered in this respect during the experiment: the percentage of patients with high cholesterol diminished signi¢cantly from the pre-BS period to the ¢rst month after the operation and thereafter remained practically constant until the third month ( Table 2) .
The correlation between BMI and every other variable measured was tested (Po0.05). A signi¢cant but weak negative correlation (r ¼ À0.328) was revealed between BMI and albumin.
Discussion
The surgical treatment of morbid obesity is indicated speci¢cally to promote a reduced ingestion of calories, in order to bring about a loss of weight and hence an improved quality of life. Few studies have been made of liver steatosis markers in the early postoperative phase and this report is intended to add to the data available.
From the second or third day after BS, the patient receives a liquid diet, taken in small volumes, and this continues for the ¢rst four weeks, allowing the digestive system to rest and to adapt to reduced intakes and the hydration. 3, 31, 32 Possibly, this regimen was responsible for the notable loss of 11% of body weight in the ¢rst month after BS, which is similar to that described by Capella and Capella. 33 By the end of three months, both the weight and the BMI had fallen by 19.2%, compared with the pre-BS values (Table1). There was also a significant fall in the serum transaminase and g-GT activities, which are used in the diagnosis of liver conditions such as steatosis (Table 1) .
Steatosis can be diagnosed by the analysis of images produced by computer-aided tomography, ultrasound and nuclear magnetic resonance, but the sensitivity of these techniques is low. 6, 34 A liver biopsy is considered the 'gold standard' in the diagnosis of liver disease. 9 However, there is a considerable risk attached to this procedure, restricting its usefulness as a routine test in the investigation and diagnosis of low-grade diseases such as steatosis. Increased serum transaminase activity has been reported to be a su⁄ciently sensitive test to indicate the presence of steatosis. 35, 36 Comparing the measured values of liver-function markers AST, ALT, ALP, g-GT, ChE, bilirubins, total protein and albumin with their reference values (Table 2) , we observed that the values of ALT and g-GT before the operation were high in 45% of the patients. In obese patients, who are not su¡ering from other liver diseases, a rise in serum levels of these enzymes is considered diagnostic for steatosis by some authors. 36--38 Although there was a tendency for the number of patients with raised ALT and g-GT activities to fall, reaching 15 and 20%, respectively, in the third month after BS, this change was not signi¢cant when tested statistically. Nevertheless, these results were wholly consistent with the signi¢cant decrease in the mean activities of these enzymes, from the pre-BS period to the third month post-BS (Table 1 ). This fall in the serum levels of these liver enzymes, following a loss of weight, corroborates earlier research performed over longer periods after surgery, in which the observed return of ALT activity to normal was interpreted as an indication that the liver steatosis had abated. 7, 35 The high levels of ALT and g-GT in the pre-BS period might have resulted from the greater over£ow of such enzymes into the blood caused by liver-cell damage. This damage could be due to oxidative stress provoked by the large in£ux of free fatty acids and their oxidation by the liver. 39, 40 In vitro studies have demonstrated that free fatty acids are potentially cytotoxic as they can destroy the integrity of membranes, provoking mitochondrial swelling and increasing the fragility of lysosomes, eventually leading to breakdown of the cell with consequent release of enzymes. 41 Therefore, the reduced levels of ALT and g-GT following weight loss could indicate a decrease in deposition of fat in the hepatocytes, owing to the disturbed lipid metabolism in the liver being repaired as the supply of free fatty acid to the liver subsides, resulting in restoration of the integrity of the cell membrane. The metabonomics of these enzymes after BS is, however, very complex, since it involves factors such as restricted diet, adaptation of the body to the surgery and activation of lipolysis.
With regard to AST, there was a reduction in the third month, albeit not signi¢cant, in the number of patients with serum levels above reference values ( Table 2 ). According to published reports, this activity may rise slightly in cases of steatosis. However, on its own this result is insu⁄cient to indicate liver damage, as AST is a less-speci¢c and sensitive marker for hepatocyte damage, owing to its presence in a wide variety of tissues (heart, skeletal muscle, erythrocytes, leukocytes, kidney, brain and liver). 12, 42 On the other hand, the signi¢cant reduction observed in serum levels of AST (Table 1 ) may be associated with the decrease in other hepatic markers (ALT and g-GT), corroborating the suggestion of slight liver damage in the phase before BS.
The present results allow direct comparison of the behaviour of the marker enzymes during the short period studied. Thus, the two transaminases (AST, ALT) show similar activity pro¢les until three months post-BS, with a ¢nal signi¢cant fall, while the markers for cholestasis, g -GT and ALP, show dissimilar patterns of variation ( Table 1) .
The lack of any change in serum levels of the bilirubins, before and after BS (Table1), shows that the excretory function of the liver was una¡ected by excess weight or weight loss, consistent with several studies that point to normal serum levels of bilirubin in the blood of obese patients with steatosis. 35,43--45 The percentage of patients with direct bilirubin (DB) concentration above reference --30, 20 and 30% in the three periods (Table 2 ) --are certainly not associated with steatosis, as they refer to DB levels of 3.42--4.28 mmol/L, minimally above normal. Contrasting with this conclusion, as already discussed, the cholestasis marker g-GT showed a tendency to fall towards its reference value (Table 2) in the period following BS. Controversy exists around the e¡ects of steatosis on ALP levels in the serum. Silverman et al. 43 reported raised activity, while others considered this result abnormal in cases of fatty overload of the liver. In the present study, ALP was unchanged throughout and completely independent of the excess and subsequent appreciable losses in weight that were observed, in agreement with the work of Satheesh. 40 Regarding ChE in the plasma, Nomura et al. 46 and Kutty et al. 47 observed increased activity in obese patients and mice with liver steatosis, which diminished on a low-calorie diet. It is possible that the high-calorie diet based on fat, protein and carbohydrate given to the mice, together with their hormonal response, would stimulate ChE production in obese animals. 47 However, these data still require wider con¢rmation since, to our knowledge, serum ChE is still rarely evaluated in obese patients. The present results contradict those of Nomura et al. 46 and Kutty et al., 47 as no alteration was found in any of the periods evaluated (Table 1 ) and the activity of ChE was close to the reference range ( Table 2 ), suggesting that neither excess weight nor the loss of weight in£uenced its value.
From the inter-period analyses, it was concluded that the weight loss did not alter the concentrations of total protein or albumin (Table 1) , con¢rming the work of other authors met. 35, 43, 48 However, Renquist et al., 49 However; observed a protein de¢cit in the ¢rst three months after BS, owing to the di⁄culty patients had in eating solid food, making them dependent on liquids and soup. Nevertheless, in the detailed data, it was possible to detect a weak negative correlation between BMI and albumin, implying that the reduction in body weight promoted by BS helped improve the synthesis of albumin in the liver, which might have su¡ered slightly from the light steatosis found before the surgery. This improved synthesis, up to the third month after BS, would not, however, be su⁄cient to re£ect in the total protein data.
Hypercholesterolaemia, a metabolic disturbance observed in obese people, was detected in 50% of the patients ( Table 2 ). The weight loss after BS apparently resulted in a signi¢cant drop in this proportion, to 20%, in the ¢rst month. Other authors have associated the loss of weight with a return of cholesterol level to normal, though in the great majority of cases this occurs about six months after surgery. 7, 50 Conversely, the mean level of cholesterol, which was 5.1571.29 mmol/L before BS, showed a non-signi¢cant fall in the ¢rst month after surgery and no further improvement occurred in the third month ( Table 1) . The increase in the number of patients with normal cholesterol levels one month after BS was associated with a fall of 11% in body weight. Nevertheless, weight loss may not be the only factor responsible for the improved lipid pro¢le, which could equally be connected with the correction of a state of hyperinsulinemia and improved tissue sensitivity to insulin. This behaviour was observed by us 50 and also by other authors. 51 An improved uptake of glucose and increased use of this sugar to produce energy would provoke a fall in the b-oxidation of free fatty acids and thus in the production of acetyl CoA, a substrate for synthesis of cholesterol and fatty acids. Furthermore, LDL rich in cholesterol are removed by the liver by means of speci¢c receptors stimulated into action by insulin. 52 There is consensus among medical practitioners that a 10% reduction in weight is su⁄cient to lead to correction of obesity-related metabolic disorders.
In summary, it can be concluded that the raised enzyme activities of ALT and g-GT in the period before bariatric surgery were possibly indicative of a mild steatosis of the liver, di¡erentiating this condition from alcoholic steatosis, in which the predominant marker enzyme is AST. 13 The decreased serum levels of ALT and g-GT, by the third month after BS, in parallel with loss of weight, suggested that BS also led to some degree of reversal of steatosis in a short time after the operation. Finally, these enzymes can be recommended as useful markers for the build-up of fat in the liver in the short term after BS.
